Cargando…
Safety Measures for Maintaining Low Endophthalmitis Rate after Intravitreal Anti-Vascular Endothelial Growth Factor Injection before and during the COVID-19 Pandemic
During the COVID-19 pandemic, intravitreal injections are performed with patients wearing masks. The risk of endophthalmitis after intravitreal injection is reported to increase due to an influx of exhaled air containing oral bacteria from the upper part of the mask onto the ocular surface. We retro...
Autores principales: | Tanaka, Koji, Shimada, Hiroyuki, Mori, Ryusaburo, Kitagawa, Yorihisa, Onoe, Hajime, Tamura, Kazuki, Nakashizuka, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837000/ https://www.ncbi.nlm.nih.gov/pubmed/35160327 http://dx.doi.org/10.3390/jcm11030876 |
Ejemplares similares
-
One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy
por: Kitagawa, Yorihisa, et al.
Publicado: (2022) -
Intravitreal Injection of 1.25% Povidone Iodine Followed by Vitrectomy Using 0.025% Povidone Iodine Irrigation for Treating Endophthalmitis
por: Nakashizuka, Hiroyuki, et al.
Publicado: (2019) -
A case of bilateral pachychoroid disease: polypoidal choroidal vasculopathy in one eye and peripheral exudative hemorrhagic chorioretinopathy in contralateral eye
por: Kitagawa, Yorihisa, et al.
Publicado: (2021) -
Central serous chorioretinopathy and heart rate variability analysis with a smartphone application
por: Takeshima, Keigo, et al.
Publicado: (2020) -
Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case report
por: Onoe, Hajime, et al.
Publicado: (2022)